Janux

PEOPLE ON THE MOVE

“We have developed a technology to engineer best-in-class T cell engagers that are potent and highly tumor specific, which is essential for an immune response that kills tumor cells but spares healthy tissue,” said David Campbell, president and CEO of...

Read latest San Diego Business Journal online.

Online newspapers at PressDisplay.